Vanda Pharms Inc Drug Patent Portfolio

Vanda Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Vanda Pharms Inc News

The FDA's Challenge with Generic Medications: Finding a Balance Between Innovation and Market Consistency - AInvest

22 Aug, 2025

See More